ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
25 May 2018Americas

FTC antitrust charges against Impax dismissed

A judge has found it unlikely that Impax Laboratories would launch a generic drug before a final court decision in related patent litigation and has dismissed a case against the company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
9 May 2018   Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.
Americas
19 October 2017   Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.

More on this story

Americas
9 May 2018   Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.
Americas
19 October 2017   Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.

More on this story

Americas
9 May 2018   Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.
Americas
19 October 2017   Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.